Skip Navigation LinksHome > May 2011 - Volume 111 - Issue 5 > New SSRI Approved
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000398044.92675.7a
Drug Watch

New SSRI Approved

Aschenbrenner, Diane S. MS, RN

Online Continuing Education
Collapse Box


* A new selective serotonin reuptake inhibitor, vilazodone hydrochloride (Viibryd), has been approved for the treatment of depression.

* Vilazodone's mechanism of action is similar to that of other drugs in the class, and it carries similar warnings and precautions.

* Vilazodone should be taken with food, which increases its bioavailability.

© 2011 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics